These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30188115)
1. Afterglow Resonance Energy Transfer Inhibition for Fibroblast Activation Protein-α Assay. Feng F; Chen X; Li G; Liang S; Hong Z; Wang HF ACS Sens; 2018 Sep; 3(9):1846-1854. PubMed ID: 30188115 [TBL] [Abstract][Full Text] [Related]
2. Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha. Li J; Chen K; Liu H; Cheng K; Yang M; Zhang J; Cheng JD; Zhang Y; Cheng Z Bioconjug Chem; 2012 Aug; 23(8):1704-11. PubMed ID: 22812530 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma. Liao Y; Xing S; Xu B; Liu W; Zhang G Oncotarget; 2017 May; 8(18):30050-30062. PubMed ID: 28415791 [TBL] [Abstract][Full Text] [Related]
4. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics. Sun SK; Wang HF; Yan XP Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602 [TBL] [Abstract][Full Text] [Related]
5. Rechargeable and LED-activated ZnGa Zhou Z; Zheng W; Kong J; Liu Y; Huang P; Zhou S; Chen Z; Shi J; Chen X Nanoscale; 2017 May; 9(20):6846-6853. PubMed ID: 28497817 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence resonance energy transfer inhibition assay for α-fetoprotein excreted during cancer cell growth using functionalized persistent luminescence nanoparticles. Wu BY; Wang HF; Chen JT; Yan XP J Am Chem Soc; 2011 Feb; 133(4):686-8. PubMed ID: 21166409 [TBL] [Abstract][Full Text] [Related]
7. Ultrasensitive Fibroblast Activation Protein-α-Activated Fluorogenic Probe Enables Selective Imaging and Killing of Melanoma Liu SY; Wang H; Nie G ACS Sens; 2022 Jul; 7(7):1837-1846. PubMed ID: 35713201 [TBL] [Abstract][Full Text] [Related]
8. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. Aertgeerts K; Levin I; Shi L; Snell GP; Jennings A; Prasad GS; Zhang Y; Kraus ML; Salakian S; Sridhar V; Wijnands R; Tennant MG J Biol Chem; 2005 May; 280(20):19441-4. PubMed ID: 15809306 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug. Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542 [TBL] [Abstract][Full Text] [Related]
10. A Novel Chemiluminescence Probe for Sensitive Detection of Fibroblast Activation Protein-Alpha In Vitro and in Living Systems. Fu A; Wang H; Huo T; Li X; Fu W; Huang R; Cao Z Anal Chem; 2021 Apr; 93(16):6501-6507. PubMed ID: 33866786 [TBL] [Abstract][Full Text] [Related]
11. Kiwifruit-like Persistent Luminescent Nanoparticles with High-Performance and in Situ Activable Near-Infrared Persistent Luminescence for Long-Term in Vivo Bioimaging. Lin XH; Song L; Chen S; Chen XF; Wei JJ; Li J; Huang G; Yang HH ACS Appl Mater Interfaces; 2017 Nov; 9(47):41181-41187. PubMed ID: 29111643 [TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α. Chai XP; Sun GL; Fang YF; Hu LH; Liu X; Zhang XW Acta Pharmacol Sin; 2018 Mar; 39(3):415-424. PubMed ID: 29119969 [TBL] [Abstract][Full Text] [Related]
13. A time-resolved luminescent competitive assay to detect L-selectin using aptamers as recognition elements. Cywiński PJ; Olejko L; Löhmannsröben HG Anal Chim Acta; 2015 Aug; 887():209-215. PubMed ID: 26320804 [TBL] [Abstract][Full Text] [Related]
14. Large Hollow Cavity Luminous Nanoparticles with Near-Infrared Persistent Luminescence and Tunable Sizes for Tumor Afterglow Imaging and Chemo-/Photodynamic Therapies. Wang J; Li J; Yu J; Zhang H; Zhang B ACS Nano; 2018 May; 12(5):4246-4258. PubMed ID: 29676899 [TBL] [Abstract][Full Text] [Related]
15. A synthetic urinary probe-coated nanoparticles sensitive to fibroblast activation protein α for solid tumor diagnosis. Feng X; Wang Q; Liao Y; Zhou X; Wang Y; Liu W; Zhang G Int J Nanomedicine; 2017; 12():5359-5372. PubMed ID: 28794628 [TBL] [Abstract][Full Text] [Related]
16. Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells. Yang L; Ma L; Lai D Acta Biochim Biophys Sin (Shanghai); 2013 Nov; 45(11):928-37. PubMed ID: 24028972 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations. Koczorowska MM; Tholen S; Bucher F; Lutz L; Kizhakkedathu JN; De Wever O; Wellner UF; Biniossek ML; Stahl A; Lassmann S; Schilling O Mol Oncol; 2016 Jan; 10(1):40-58. PubMed ID: 26304112 [TBL] [Abstract][Full Text] [Related]
18. X-ray/red-light excited ZGGO:Cr,Nd nanoprobes for NIR-I/II afterglow imaging. Jiang R; Yang J; Meng Y; Yan D; Liu C; Xu C; Liu Y Dalton Trans; 2020 May; 49(18):6074-6083. PubMed ID: 32319478 [TBL] [Abstract][Full Text] [Related]
19. The stromal cell-surface protease fibroblast activation protein-α localizes to lipid rafts and is recruited to invadopodia. Knopf JD; Tholen S; Koczorowska MM; De Wever O; Biniossek ML; Schilling O Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2515-25. PubMed ID: 26209915 [TBL] [Abstract][Full Text] [Related]
20. Luciferase expression is driven by the promoter of fibroblast activation protein-α in murine pulmonary fibrosis. Wenlong L; Leilei Y; Wei F; Yi C; Jing T; Lanzhi M; Bing L; Yang L; Shaoxia W; Qiuxia F; Zeliang C; Zengming Z Biotechnol Lett; 2015 Sep; 37(9):1757-63. PubMed ID: 25994578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]